ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : CELLULAR THERAPY FOR
Australian State/Territory : NSW
Field of Research : Molecular Targets
Clear All
Filter by Field of Research
Molecular Targets (4)
Cancer Cell Biology (2)
Cancer Therapy (excl. Chemotherapy and Radiation Therapy) (2)
Oncology and Carcinogenesis (2)
Cardiorespiratory Medicine and Haematology (1)
Cellular Immunology (1)
Reproduction (1)
Respiratory Diseases (1)
Filter by Socio-Economic Objective
Cancer and Related Disorders (3)
Reproductive System and Disorders (1)
Respiratory System and Diseases (incl. Asthma) (1)
Filter by Funding Provider
Australian Research Council (3)
National Health and Medical Research Council (1)
Filter by Status
Closed (4)
Filter by Scheme
ARC Future Fellowships (1)
Discovery Projects (1)
Linkage Infrastructure, Equipment and Facilities (1)
Project Grants (1)
Filter by Country
Australia (3)
Filter by Australian State/Territory
NSW (3)
QLD (1)
  • Researchers (6)
  • Funded Activities (4)
  • Organisations (7)
  • Funded Activity

    ARC Future Fellowships - Grant ID: FT120100323

    Funder
    Australian Research Council
    Funding Amount
    $697,088.00
    Summary
    The critical role of the class III histone deacetylase SIRT2 in stabilizing N-Myc oncoprotein. Cancer is the commonest cause of death from disease in children. Neuroblastoma is the commonest solid tumor in early childhood. This project will investigate the critical roles of SIRT2 protein in increasing the expression of N-Myc oncoprotein and consequently inducing neuroblastoma, and SIRT2 inhibitors as anticancer agents.
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP110105009

    Funder
    Australian Research Council
    Funding Amount
    $310,000.00
    Summary
    Mitochondrially targeted anti-cancer drugs modulate the mitochondrial genome. Successful cancer management requires novel therapeutical approaches. This project will test the effect of a new class of compounds that target mitochondria, the powerhouse of the cells, where they suppress expression of mitochondrial genes. By this mechanism, cancers that are resistant to apoptosis induction can be inhibited.
    More information
    Funded Activity

    ADAM Metalloprotease Inhibition For Treatment Of Colorectal Cancer

    Funder
    National Health and Medical Research Council
    Funding Amount
    $770,925.00
    Summary
    Colorectal cancer (CRC) causes over 4000 deaths/year, typically from developing drug resistance and spreading to other organs (metastasis). These processes involve tumour cells called cancer stem cells (CSCs), which rely on specific cell surface proteins for survival and function. We are developing antibodies against one of these type of proteins, to test in mouse models of CRC. These already show promise in targeting CSCs and inhibiting drug-resistance and metastasis in mice.
    More information
    Funded Activity

    Linkage Infrastructure, Equipment And Facilities - Grant ID: LE120100082

    Funder
    Australian Research Council
    Funding Amount
    $180,000.00
    Summary
    FACSAria III - Fluorescence activated cell sorter. Flow cytometry is a technique for counting and examining microscopic particles, such as cells and chromosomes, by suspending them in a stream of fluid and passing them by an electronic detection apparatus. The FACSAria III cell sorter will be used to establish a core facility for sorting cells. The outcomes from using this technology are a better understanding cellular and genetic understanding of cancer, respiratory diseases, reproduction and .... FACSAria III - Fluorescence activated cell sorter. Flow cytometry is a technique for counting and examining microscopic particles, such as cells and chromosomes, by suspending them in a stream of fluid and passing them by an electronic detection apparatus. The FACSAria III cell sorter will be used to establish a core facility for sorting cells. The outcomes from using this technology are a better understanding cellular and genetic understanding of cancer, respiratory diseases, reproduction and birth.
    Read more Read less
    More information

    Showing 1-4 of 4 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback